Jon Clouse

635 total citations
17 papers, 494 citations indexed

About

Jon Clouse is a scholar working on Economics and Econometrics, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Jon Clouse has authored 17 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 4 papers in General Health Professions and 4 papers in Geriatrics and Gerontology. Recurrent topics in Jon Clouse's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Healthcare Policy and Management (5 papers) and Pharmaceutical Economics and Policy (4 papers). Jon Clouse is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Healthcare Policy and Management (5 papers) and Pharmaceutical Economics and Policy (4 papers). Jon Clouse collaborates with scholars based in United States, South Korea and China. Jon Clouse's co-authors include Lois Quam, Lynda B.M. Ellis, Sheila Leatherman, David W. Lee, Jay Meyer, Deborah Shatin, Carol R. Drinkard, Alan L. Hillman, José J. Escarce and Martin Gaynor and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and Medical Care.

In The Last Decade

Jon Clouse

17 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Clouse United States 8 150 127 94 68 64 17 494
Paul Nichol United States 13 103 0.7× 85 0.7× 179 1.9× 166 2.4× 50 0.8× 17 707
Deanna K. Martin United States 13 203 1.4× 103 0.8× 85 0.9× 77 1.1× 29 0.5× 16 1.0k
J. Thain United Kingdom 6 123 0.8× 66 0.5× 236 2.5× 144 2.1× 117 1.8× 8 713
Kim Reimer Canada 14 64 0.4× 58 0.5× 108 1.1× 95 1.4× 42 0.7× 17 609
Shelly Vik Canada 10 114 0.8× 86 0.7× 64 0.7× 69 1.0× 12 0.2× 18 614
Celia Shmukler United States 12 68 0.5× 37 0.3× 186 2.0× 89 1.3× 73 1.1× 15 822
Angeline M. Carlson United States 14 74 0.5× 106 0.8× 70 0.7× 54 0.8× 7 0.1× 38 648
Barbara M Rothenberg United States 11 181 1.2× 58 0.5× 135 1.4× 30 0.4× 14 0.2× 17 541
A Hartz United States 12 44 0.3× 55 0.4× 95 1.0× 136 2.0× 20 0.3× 17 559
Ulrik Hesse Denmark 11 70 0.5× 59 0.5× 88 0.9× 50 0.7× 17 0.3× 21 483

Countries citing papers authored by Jon Clouse

Since Specialization
Citations

This map shows the geographic impact of Jon Clouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Clouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Clouse more than expected).

Fields of papers citing papers by Jon Clouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Clouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Clouse. The network helps show where Jon Clouse may publish in the future.

Co-authorship network of co-authors of Jon Clouse

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Clouse. A scholar is included among the top collaborators of Jon Clouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Clouse. Jon Clouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lal, Lincy S., et al.. (2011). Managing specialty medication services through a network of specialty pharmacies: A case of oral oncology medications.. Journal of Clinical Oncology. 29(15_suppl). 6132–6132. 3 indexed citations
2.
Clouse, Jon. (2002). Establishing value in managed care: Cost-effectiveness or budgetary impact?. Journal of Allergy and Clinical Immunology. 109(5). S511–S513. 1 indexed citations
3.
Clouse, Jon, et al.. (2002). Health economic considerations in the management of type 2 diabetes.. PubMed. 15(1). 66–71. 5 indexed citations
4.
Lee, David W., Jay Meyer, & Jon Clouse. (2001). Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective. Value in Health. 4(4). 329–334. 43 indexed citations
5.
Lee, David W., Jay Meyer, & Jon Clouse. (2001). Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective. Value in Health. 4(4). 329–334. 5 indexed citations
6.
Sullivan, Erin, Robert I. Griffiths, Richard G. Frank, et al.. (2000). One-Year Costs of Second-Line Therapies for Depression. The Journal of Clinical Psychiatry. 61(4). 290–298. 11 indexed citations
7.
Drinkard, Carol R., Deborah Shatin, & Jon Clouse. (2000). Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations*. Pharmacoepidemiology and Drug Safety. 9(7). 549–556. 35 indexed citations
8.
Park, Byung‐Joo, Jon Clouse, Deborah Shatin, & Andy Stergachis. (2000). Incidence of adverse oesophageal and gastric events in alendronate users. Pharmacoepidemiology and Drug Safety. 9(5). 371–376. 6 indexed citations
9.
Griffiths, Robert I., Erin Sullivan, Richard G. Frank, et al.. (1999). Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy. PharmacoEconomics. 15(5). 495–505. 14 indexed citations
10.
Gagnon, Jean Paul, Donna Rindress, Patricia A. Deverka, et al.. (1999). Pharmacoeconomics: Identifying the Issues Overview and Advisory Panel Report Summary. Value in Health. 2(2). 67–72. 3 indexed citations
11.
Clouse, Jon, et al.. (1999). Panel 5: Application of Healthcare Intervention Economic Evaluations in Healthcare Decision-Making. Value in Health. 2(2). 92–98. 1 indexed citations
12.
Hillman, Alan L., et al.. (1999). Financial Incentives And Drug Spending In Managed Care. Health Affairs. 18(2). 189–200. 70 indexed citations
13.
Connors, Heather, Muriel A. Cleary, & Jon Clouse. (1999). TPCP2: PERCENTAGE OF ANTI-HYPERTENSIVE DRUGS “FILLED AS INTENDED” COMPARING PHARMACY CLAIMS AND MEDICAL RECORDS DATA. Value in Health. 2(3). 147–148. 1 indexed citations
14.
Clouse, Jon. (1995). The Effect of Methodological Advances in Health Economics on the Marketplace. Drug Information Journal. 29(4). 1429–1430. 1 indexed citations
15.
Clouse, Jon, et al.. (1994). Healthcare Resource Use and Costs Associated with Migraine in a Managed Healthcare Setting. Annals of Pharmacotherapy. 28(5). 659–664. 105 indexed citations
16.
Re, Brown, et al.. (1994). Patient adherence to prescribed potassium supplement therapy.. PubMed. 15(6). 1133–45; discussion 1120. 8 indexed citations
17.
Quam, Lois, et al.. (1993). Using Claims Data for Epidemiologic Research. Medical Care. 31(6). 498–507. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026